vs

Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and POTLATCHDELTIC CORP (PCH). Click either name above to swap in a different company.

POTLATCHDELTIC CORP is the larger business by last-quarter revenue ($314.2M vs $284.0M, roughly 1.1× ACADIA PHARMACEUTICALS INC). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs 8.2%, a 88.1% gap on every dollar of revenue. On growth, POTLATCHDELTIC CORP posted the faster year-over-year revenue change (23.1% vs 9.4%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (17.5% CAGR vs 11.1%).

Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.

PotlatchDeltic Corporation is an American diversified forest products company based in Spokane, Washington.

ACAD vs PCH — Head-to-Head

Bigger by revenue
PCH
PCH
1.1× larger
PCH
$314.2M
$284.0M
ACAD
Growing faster (revenue YoY)
PCH
PCH
+13.8% gap
PCH
23.1%
9.4%
ACAD
Higher net margin
ACAD
ACAD
88.1% more per $
ACAD
96.3%
8.2%
PCH
Faster 2-yr revenue CAGR
ACAD
ACAD
Annualised
ACAD
17.5%
11.1%
PCH

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
ACAD
ACAD
PCH
PCH
Revenue
$284.0M
$314.2M
Net Profit
$273.6M
$25.9M
Gross Margin
90.8%
18.2%
Operating Margin
6.1%
11.2%
Net Margin
96.3%
8.2%
Revenue YoY
9.4%
23.1%
Net Profit YoY
90.3%
682.5%
EPS (diluted)
$1.61
$0.33

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACAD
ACAD
PCH
PCH
Q4 25
$284.0M
Q3 25
$278.6M
$314.2M
Q2 25
$264.6M
$275.0M
Q1 25
$244.3M
$268.3M
Q4 24
$259.6M
$258.1M
Q3 24
$250.4M
$255.1M
Q2 24
$242.0M
$320.7M
Q1 24
$205.8M
$228.1M
Net Profit
ACAD
ACAD
PCH
PCH
Q4 25
$273.6M
Q3 25
$71.8M
$25.9M
Q2 25
$26.7M
$7.4M
Q1 25
$19.0M
$25.8M
Q4 24
$143.7M
$5.2M
Q3 24
$32.8M
$3.3M
Q2 24
$33.4M
$13.7M
Q1 24
$16.6M
$-305.0K
Gross Margin
ACAD
ACAD
PCH
PCH
Q4 25
90.8%
Q3 25
92.2%
18.2%
Q2 25
92.2%
13.0%
Q1 25
91.7%
17.8%
Q4 24
91.6%
13.4%
Q3 24
92.5%
10.8%
Q2 24
92.5%
11.9%
Q1 24
88.8%
7.0%
Operating Margin
ACAD
ACAD
PCH
PCH
Q4 25
6.1%
Q3 25
12.8%
11.2%
Q2 25
12.2%
5.0%
Q1 25
7.9%
10.3%
Q4 24
59.1%
5.2%
Q3 24
12.6%
2.8%
Q2 24
12.6%
5.4%
Q1 24
7.4%
-2.1%
Net Margin
ACAD
ACAD
PCH
PCH
Q4 25
96.3%
Q3 25
25.8%
8.2%
Q2 25
10.1%
2.7%
Q1 25
7.8%
9.6%
Q4 24
55.4%
2.0%
Q3 24
13.1%
1.3%
Q2 24
13.8%
4.3%
Q1 24
8.0%
-0.1%
EPS (diluted)
ACAD
ACAD
PCH
PCH
Q4 25
$1.61
Q3 25
$0.42
$0.33
Q2 25
$0.16
$0.09
Q1 25
$0.11
$0.33
Q4 24
$0.86
$0.07
Q3 24
$0.20
$0.04
Q2 24
$0.20
$0.17
Q1 24
$0.10
$0.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACAD
ACAD
PCH
PCH
Cash + ST InvestmentsLiquidity on hand
$177.7M
$88.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.2B
$1.9B
Total Assets
$1.6B
$3.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACAD
ACAD
PCH
PCH
Q4 25
$177.7M
Q3 25
$258.0M
$88.8M
Q2 25
$253.6M
$95.3M
Q1 25
$217.7M
$147.5M
Q4 24
$319.6M
$151.6M
Q3 24
$155.1M
$161.1M
Q2 24
$177.1M
$199.7M
Q1 24
$204.7M
$180.2M
Total Debt
ACAD
ACAD
PCH
PCH
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$1.0B
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ACAD
ACAD
PCH
PCH
Q4 25
$1.2B
Q3 25
$917.3M
$1.9B
Q2 25
$822.4M
$1.9B
Q1 25
$765.2M
$2.0B
Q4 24
$732.8M
$2.0B
Q3 24
$577.2M
$2.1B
Q2 24
$516.7M
$2.1B
Q1 24
$464.0M
$2.2B
Total Assets
ACAD
ACAD
PCH
PCH
Q4 25
$1.6B
Q3 25
$1.3B
$3.2B
Q2 25
$1.2B
$3.2B
Q1 25
$1.1B
$3.3B
Q4 24
$1.2B
$3.3B
Q3 24
$976.9M
$3.3B
Q2 24
$914.1M
$3.4B
Q1 24
$855.1M
$3.4B
Debt / Equity
ACAD
ACAD
PCH
PCH
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.51×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACAD
ACAD
PCH
PCH
Operating Cash FlowLast quarter
$-48.7M
$65.7M
Free Cash FlowOCF − Capex
$50.1M
FCF MarginFCF / Revenue
15.9%
Capex IntensityCapex / Revenue
4.9%
Cash ConversionOCF / Net Profit
-0.18×
2.54×
TTM Free Cash FlowTrailing 4 quarters
$132.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACAD
ACAD
PCH
PCH
Q4 25
$-48.7M
Q3 25
$74.3M
$65.7M
Q2 25
$64.0M
$41.0M
Q1 25
$20.3M
$49.1M
Q4 24
$40.4M
$45.4M
Q3 24
$63.2M
$26.5M
Q2 24
$25.0M
$100.6M
Q1 24
$29.1M
$16.0M
Free Cash Flow
ACAD
ACAD
PCH
PCH
Q4 25
Q3 25
$73.9M
$50.1M
Q2 25
$30.6M
Q1 25
$26.3M
Q4 24
$25.4M
Q3 24
$63.2M
$-8.2M
Q2 24
$72.4M
Q1 24
$2.0M
FCF Margin
ACAD
ACAD
PCH
PCH
Q4 25
Q3 25
26.5%
15.9%
Q2 25
11.1%
Q1 25
9.8%
Q4 24
9.9%
Q3 24
25.2%
-3.2%
Q2 24
22.6%
Q1 24
0.9%
Capex Intensity
ACAD
ACAD
PCH
PCH
Q4 25
Q3 25
0.1%
4.9%
Q2 25
3.8%
Q1 25
8.5%
Q4 24
7.7%
Q3 24
0.0%
13.6%
Q2 24
8.8%
Q1 24
6.1%
Cash Conversion
ACAD
ACAD
PCH
PCH
Q4 25
-0.18×
Q3 25
1.03×
2.54×
Q2 25
2.40×
5.58×
Q1 25
1.07×
1.90×
Q4 24
0.28×
8.74×
Q3 24
1.93×
7.99×
Q2 24
0.75×
7.35×
Q1 24
1.76×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACAD
ACAD

Nuplazid$174.4M61%
Daybue$109.6M39%

PCH
PCH

Lumber$131.8M42%
Timberlands$52.5M17%
Rural Real Estate$51.3M16%
Residuals And Panels$34.0M11%
Pulpwood$16.7M5%
Development Real Estate$14.6M5%
Other$8.1M3%
Other Products$5.2M2%

Related Comparisons